VDAC1 and breast cancer: We showed that depleting VDAC1, which is overexpressed in many tumors, including GBM and lung and breast cancers,7, 9, 46 resulted in a decreased expression of glycolysis-, Kreb’s cycle-, and OXPHOS-related enzymes, reflecting reduced anaplerotic and OXPHOS reactions.